[Benzodiazepine receptor in the central nervous system and its natural and synthetic agonists and antagonists. Clinical uses].
Feldman
R
R
D014151:Anti-Anxiety Agents / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000506:poisoning; D000931:Antidotes; D001921:Brain / Q000378:metabolism*; D002243:Carbolines / Q000378:metabolism*; D026261:Diazepam Binding Inhibitor; D004341:Drug Evaluation; D005442:Flumazenil / Q000627:therapeutic use*; D006801:Humans; D009479:Neuropeptides / Q000627:therapeutic use*; D011963:Receptors, GABA-A / Q000187:drug effects / Q000378:metabolism*
D014151:Anti-Anxiety Agents; D000931:Antidotes; D002243:Carbolines; D026261:Diazepam Binding Inhibitor; D009479:Neuropeptides; D011963:Receptors, GABA-A; D005442:Flumazenil
Receptor benzodwuazepinowy w ośrodkowym układzie nerwowym, jego naturalni i syntetyczni agoniści i antagoniści. Zastosowania kliniczne.